Canton Strategic Holdings, Inc. (CNTN) Form 8-K — Jul 23, 2026

$CNTNForm 8-KItems 1.01, 2.01, 8.01, 9.01Filed Jul 23, 2026, 8:40 AM ET0001493152-26-034340Original filing

Canton Strategic Holdings, Inc. has completed the sale of its wholly-owned subsidiary, Gravitas Life Sciences, LLC, to Gravitas Collective Corp., an entity affiliated with former directors of the Company. The transaction closed on July 17, 2026, with consideration consisting of a $3.5 million unsecured promissory note bearing 15% interest, maturing in 2029, along with potential future milestone payments. In connection with the sale, the company retained certain assets related to bispecific antibodies development through its subsidiary Tharimmune SPV1.

Key figures

Debt Amount: 3500000
Total Assets: 586523091
Cash Position: 40001283
Interest Rate: 15%
Maturity Date: 2029-07-17
Digital Assets: 541569363
Note Receivable: 3500000
Pro Forma Asset Change: 1868478

Price after filing

1 day: -10.2%7 days: -14.4%30 days: +1.4%

Close on the filing date to close N calendar days later (from $2.16). Historical, not a forecast.

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.